Cotrimoxazole‐induced hyperkalemia in renal transplant patient—Case report

We present the case of a 55‐year‐old male patient who developed hyperkalemia after using Cotrimoxazole (TMP‐SMX). There was a marked increase in potassium levels from 3.3 mEq/L on Day 5 when cotrimoxazole was started to 6.2 mEq/L on Day 11 when the drug was withheld.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical Case Reports 2022-10, Vol.10 (10), p.e6509-n/a
Hauptverfasser:	Srikaram, Prakhyath, Siddiqui, Amna, Gul, Fahad, Deuja, Puja, Fatima, Nabeela
Format:	Artikel
Sprache:	eng
Schlagworte:	Antithymocyte globulin Blood transfusions Case Report Case reports Chronic illnesses Chronic kidney failure Co-trimoxazole Conflicts of interest cotrimoxazole Creatinine Drug dosages Drug withdrawal Ejection fraction Hemodialysis High density lipoprotein Hyperkalemia Immunosuppressive agents Kidney diseases Kidney transplants Kidneys Laboratories Pantoprazole Patients Potassium TMP‐SMX Transplantation Tuberculosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	We present the case of a 55‐year‐old male patient who developed hyperkalemia after using Cotrimoxazole (TMP‐SMX). There was a marked increase in potassium levels from 3.3 mEq/L on Day 5 when cotrimoxazole was started to 6.2 mEq/L on Day 11 when the drug was withheld.
ISSN:	2050-0904 2050-0904
DOI:	10.1002/ccr3.6509